The progression of Duchenne muscular dystrophy

A 12-month clinical study of Duchenne muscular dystrophy was carried out during a double-blind trial of allopurinol therapy. The disease was monitored by assessment of muscle power and function, pulmonary function tests, and electrocardiography. Biochemical assessments were made of plasma creatine kinase, pyruvate kinase, uric acid, and urinary excretion of 3-methylhistidine and creatinine. Allopurinol did not alter the progression of the disease.

[1]  F. Ballard,et al.  Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion. , 1979, Clinical science.

[2]  F. Ballard,et al.  Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion. , 1979, Clinical science.

[3]  J. Mendell,et al.  Lack of benefit of allopurinol in duchenne dystrophy , 1979, Muscle & nerve.

[4]  W. Thomson,et al.  Allopurinol in Duchenne's muscular dystrophy. , 1978, New England Journal of Medicine.

[5]  W. Thomson,et al.  X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: effects of oral allopurinol and adenylate. , 1978, Metabolism: clinical and experimental.

[6]  O. Khoo,et al.  Allopurinol associated hypersensitivity reactions: cutaneous and renal manifestations. , 1977, Australian and New Zealand journal of medicine.

[7]  R. Butler,et al.  Massive hepatic necrosis in a patient receiving allopurinol. , 1977, JAMA.

[8]  I. Smith,et al.  X-LINKED RECESSIVE (DUCHENNE) MUSCULAR DYSTROPHY AND PURINE METABOLISM , 1976, The Lancet.

[9]  B. Mokri,et al.  Duchenne dystrophy , 1975, Neurology.

[10]  S. Inkley,et al.  Pulmonary function in Duchenne muscular dystrophy related to stage of disease. , 1974, The American journal of medicine.

[11]  E. Bernt,et al.  Colorimetric Assay of Reitman and Frankel , 1974 .

[12]  E. Bernt,et al.  Pyruvate Kinase Assay in Serum and Erythrocytes , 1974 .

[13]  P. Band,et al.  Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. , 1970, The New England journal of medicine.

[14]  G. L. Kantor.  Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. , 1970, JAMA.

[15]  H. Levison,et al.  Standards of pulmonary function in children. , 1969, The American review of respiratory disease.

[16]  M Kitamura,et al.  [Uric acid]. , 1967, Nihon rinsho. Japanese journal of clinical medicine.

[17]  M. Nojima.  [REHABILITATION IN PROGRESSIVE MUSCULAR DYSTROPHY]. , 1965, Seikeigeka. Orthopedic surgery.

[18]  C. Caro,et al.  Some effects of restriction of chest cage expansion on pulmonary function in man: an experimental study. , 1960, The Journal of clinical investigation.

[19]  F. R. Ober.  PHYSICAL THERAPY IN INFANTILE PARALYSIS , 1938 .